Global Digital PCR Market By Components And Services (DPCR Instruments, Reagents And Consumables, DPCR Software And Services), By Applications (Clinical, Research, Forensics) - Growth, Future Prospects & Competitive Analysis, 2016 - 2023

Digital Polymerase Chain Reaction (dPCR) is a technologically advanced version of traditional polymerase chain reaction (PCR). dPCR is more sensitive and reliable technique with improved ability to quantify the absolute amount of nucleic acid. It divides the sample into large number of fragments, each containing either one or no template nucleic acid sequence.

The report titled “Global Digital PCR Market - Growth, Share, Opportunities and Competitive Analysis, 2016–2023” offers strategic insights into the overall digital PCR market along with the market size and estimates for the duration 2016 to 2023. The said research study covers in-depth analysis of multiple market segments based on type of components and services, type of applications, and different geographical region. The components and services type segment studied for analyzing the overall digital PCR market is majorly segmented into dPCR instruments, reagents and consumable, dPCR software and service. On the type of application, the digital PCR market is segmented into clinical applications, research application and forensic applications.

In order to help strategic decision makers, the report also includes competitive profiling of the leading players in digital PCR market, attractive investment proposition market positioning of key manufacturers sections. Other in-depth analysis provided in the report includes:

Geographically, the global digital PCR market is studied for the following regional markets:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East and Africa
•  

Market size and forecast for these regional and country level markets are presented in this study for the period 2013-2023. Market growth rates for the forecast period 2016-2023 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global digital PCR market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global digital PCR market. This report concludes with company profiles section that highlights major information about the key players engaged in global digital PCR market. In-depth competitive environment analysis and historical years (2013 & 2014) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global digital PCR market, offering market size and estimates for the period from 2016 to 2023, keeping in mind the above-mentioned factors.

Based on the type of application the digital PCR market is segmented as follows:

• Clinical Application
• Research Application
• Forensic Application
•  

Digital PCR techniques have lined the way for innovation in molecular diagnostics and life sciences research through its most potential features such as absolute detection and quantification of genetic materials such as DNA and RNA. The digital PCR industry has been experiencing an upward trend with a swift growth rate despite the economic turmoil, hence promising a positive growth potential. The global digital PCR market is segmented into applications such as clinical applications, research applications and forensics applications. The research segment held the largest share in the overall digital PCR market by applications. The rising application in the drug discovery and biomarker discovery for cancer treatment is driving the research application segment. The forensics application is anticipated to grow at the highest CAGR during the forecast period owing to the growing need of effective and quick results in the crime investigation at available resources. This has driven the digital PCR application in the forensics applications.

Based on the type of components and services the digital PCR market is segmented as follows:

• dPCR Instruments
• Reagents and Consumables
• dPCD software and Services
•  

Digital PCR is among the most powerful technologies in molecular biology that enables us to produce millions of copies of DNA sequences at the quickest possible time. PCR is an indispensable tool used in medical and biotechnology research across applications such as DNA cloning, functional analysis of viral, bacterial and human genes, forensic science, and diagnosis of hereditary diseases and beyond. The digital PCR industry has been experiencing an upward trend with a swift growth rate despite the economic turmoil, hence promising a positive growth potential. 

During the recent years, this gene amplification technology has been significantly supported by the growing demand from molecular diagnostics. On the basis of components and services the global digital PCR market is segmented into dPCR instruments, reagents and consumables and dPCD software and services. Being the most frequently used and replenished components in dPCR, the reagents segment is estimated to have significant market share. Moreover, it is also expected that the segment will progress at a rapid CAGR over the forecast period. Some of the key products in this segment include amplification reagents, primers, probes and panels, plastic and glass consumables, plates and reaction vessels.

For the purpose of this study, the global digital PCR market is categorized into:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

As of the current market scenario, North America is the largest regional market for dPCR technology. The highest market share of the region is attributed to existence of evolved healthcare and biotechnology research infrastructure, swift entry of novel products in the U.S. market, and favorable private and public funding in research and development. In addition, initiatives taken by local governments to enhance public healthcare by introducing novel drugs to the public significantly contributes to the dominance of this region.

Among the products and services, reagents and consumables account for the largest contribution in market revenue. Increasing R&D activities and academic research will further heighten the demand for reagents and consumables. Asia Pacific is expected to be the fastest progressing market during the forecast period. The competitors in the Asia Pacific dPCR market are budding and are perpetually working introducing new clinical uses to augment value of dPCR technology. Some prime factors attributed to the progress of Asia Pacific market include rapid entry of market leaders in the region, escalated status of Asia Pacific as a hub for CRO and CMO activities, and rapid evolution of healthcare and life sciences research infrastructure.